2006
DOI: 10.1089/sur.2006.7.269
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial Resistance of Pseudomonas aeruginosa Strains Isolated from Surgical Infections in a 7-Year Period at a General Hospital in Venezuela

Abstract: In our setting, cefepime is most active against strains of P. aeruginosa. In comparison with third-generation cephalosporins, cefepime may be less likely to induce resistance. Surveillance of antimicrobial activity should be done periodically to guide therapy of surgical infections.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(11 citation statements)
references
References 8 publications
0
10
0
1
Order By: Relevance
“…Bacterial resistance is recognized as a major factor determining morbidity, mortality and costs in tertiary hospitals 2,6,7 . Several lines of evidence suggest that there is a causal association between the use of antimicrobial agents and the prevalence of drug resistance in micro‐organisms 8,10,16,17 .…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Bacterial resistance is recognized as a major factor determining morbidity, mortality and costs in tertiary hospitals 2,6,7 . Several lines of evidence suggest that there is a causal association between the use of antimicrobial agents and the prevalence of drug resistance in micro‐organisms 8,10,16,17 .…”
Section: Resultsmentioning
confidence: 99%
“…Rodriguez et al. showed varying rates of resistance by P. aeruginosa isolates: 30·9% to gentamicin, 22·5% to ciprofloxacin, 17·6% to amikacin, 13·6% to imipenem/cilastatin, and 8% to cefepime in Venezuelan surgery hospitals 6 …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Aztreonam has also been shown to be effective for the treatment of Pseudomonas aeruginosa septic arthritis and osteomyelitis [23]. Aztreonam has been effectively used for the treatment of some multiresistant gram-negative bacteria and some antimicrobial-resistant strains of Pseudomonas aeruginosa [24,25]; however, other investigations have revealed that there are a growing number of aztreonam-resistant strains of Pseudomonas aeruginosa [26].…”
Section: Monobactammentioning
confidence: 99%